French regulators have identified another Indian API maker they say lacks just about every kind of good manufacturing practice needed to produce acceptable drugs, sanitation, data integrity and sample control. As a result, they have recommended the European Medicines Agency recall all of its products and not allow them to be used in any new drugs.
Krebs Biochemicals & Industries Ltd. fails EDQM Inspection
Ipca Labs to Acquire Additional 26% Stake in Krebs Biochemicals Through Open Offer